21-44806959-T-C
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_006936.3(SUMO3):āc.304A>Gā(p.Ser102Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000867 in 1,613,952 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_006936.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SUMO3 | NM_006936.3 | c.304A>G | p.Ser102Gly | missense_variant | 4/4 | ENST00000332859.11 | NP_008867.2 | |
SUMO3 | NM_001286416.2 | c.418A>G | p.Ser140Gly | missense_variant | 4/4 | NP_001273345.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SUMO3 | ENST00000332859.11 | c.304A>G | p.Ser102Gly | missense_variant | 4/4 | 1 | NM_006936.3 | ENSP00000330343.7 | ||
SUMO3 | ENST00000411651.6 | c.418A>G | p.Ser140Gly | missense_variant | 4/4 | 2 | ENSP00000409666.2 | |||
SUMO3 | ENST00000397898.7 | c.354A>G | p.Thr118Thr | synonymous_variant | 4/4 | 3 | ENSP00000380995.3 | |||
SUMO3 | ENST00000479153.1 | n.394A>G | non_coding_transcript_exon_variant | 4/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152154Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461798Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 727184
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152154Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74324
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at